These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 3494766

  • 1. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
    Pober JS, Lapierre LA, Stolpen AH, Brock TA, Springer TA, Fiers W, Bevilacqua MP, Mendrick DL, Gimbrone MA.
    J Immunol; 1987 May 15; 138(10):3319-24. PubMed ID: 3494766
    [Abstract] [Full Text] [Related]

  • 2. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.
    Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA.
    J Immunol; 1986 Mar 01; 136(5):1680-7. PubMed ID: 3485132
    [Abstract] [Full Text] [Related]

  • 3. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells.
    Pober JS.
    Ciba Found Symp; 1987 Mar 01; 131():170-84. PubMed ID: 3330009
    [Abstract] [Full Text] [Related]

  • 4. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.
    Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA.
    J Immunol; 1986 Sep 15; 137(6):1893-6. PubMed ID: 3091693
    [Abstract] [Full Text] [Related]

  • 5. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
    Kasid A, Director EP, Stovroff MC, Lotze MT, Rosenberg SA.
    Cancer Res; 1990 Aug 15; 50(16):5072-6. PubMed ID: 1696166
    [Abstract] [Full Text] [Related]

  • 6. ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon gamma, tumor necrosis factor-alpha and interleukin 1 beta.
    May MJ, Ager A.
    Eur J Immunol; 1992 Jan 15; 22(1):219-26. PubMed ID: 1346111
    [Abstract] [Full Text] [Related]

  • 7. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    Broudy VC, Harlan JM, Adamson JW.
    J Immunol; 1987 Jun 15; 138(12):4298-302. PubMed ID: 3495589
    [Abstract] [Full Text] [Related]

  • 8. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma.
    Thornhill MH, Haskard DO.
    J Immunol; 1990 Aug 01; 145(3):865-72. PubMed ID: 1695647
    [Abstract] [Full Text] [Related]

  • 9. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.
    Batten P, Yacoub MH, Rose ML.
    Immunology; 1996 Jan 01; 87(1):127-33. PubMed ID: 8666424
    [Abstract] [Full Text] [Related]

  • 10. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM, Vilcek J.
    J Immunol; 1987 Nov 15; 139(10):3330-7. PubMed ID: 3119705
    [Abstract] [Full Text] [Related]

  • 11. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
    Stemme S, Fager G, Hansson GK.
    Immunology; 1990 Feb 15; 69(2):243-9. PubMed ID: 2106484
    [Abstract] [Full Text] [Related]

  • 12. Modulation of human endothelial cell activation by antiproliferative cytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action.
    Delomenie C, Wautier-Pepin MP, Chappey O, Wautier JL.
    Exp Cell Res; 1993 Jul 15; 207(1):122-30. PubMed ID: 7686496
    [Abstract] [Full Text] [Related]

  • 13. Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1.
    Bussolino F, Camussi G, Tetta C, Garbarino G, Bosia A, Baglioni C.
    J Lipid Mediat; 1990 Jul 15; 2 Suppl():S15-22. PubMed ID: 2133280
    [Abstract] [Full Text] [Related]

  • 14. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts.
    Kurt-Jones EA, Fiers W, Pober JS.
    J Immunol; 1987 Oct 01; 139(7):2317-24. PubMed ID: 3116078
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.
    Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO.
    J Immunol; 1991 Jan 15; 146(2):592-8. PubMed ID: 1702807
    [Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cells.
    Locksley RM, Heinzel FP, Shepard HM, Agosti J, Eessalu TE, Aggarwal BB, Harlan JM.
    J Immunol; 1987 Sep 15; 139(6):1891-5. PubMed ID: 3497981
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS, Berger AE, Ware CF.
    J Immunol; 1990 Apr 01; 144(7):2582-91. PubMed ID: 1969453
    [Abstract] [Full Text] [Related]

  • 18. Cytokine activation of human macro- and microvessel-derived endothelial cells.
    Gerritsen ME, Niedbala MJ, Szczepanski A, Carley WW.
    Blood Cells; 1993 Apr 01; 19(2):325-39; discussion 340-2. PubMed ID: 7906155
    [Abstract] [Full Text] [Related]

  • 19. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
    Elner SG, Elner VM, Bian ZM, Lukacs NW, Kurtz RM, Strieter RM, Kunkel SL.
    Invest Ophthalmol Vis Sci; 1997 Feb 01; 38(2):446-55. PubMed ID: 9040478
    [Abstract] [Full Text] [Related]

  • 20. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.
    Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL.
    J Immunol; 1992 Dec 15; 149(12):3881-8. PubMed ID: 1281193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.